You are here: Industry Insights > COVID-19

News List

Health Canada authorises remdesivir as first Covid-19 treatment pharmaceutical-technology
July 30, 2020
Health Canada has granted conditional approval to Gilead Sciences’ remdesivir (Veklury) to treat patients with severe Covid-19 who have pneumonia and need oxygen support.
US DFC to offer $765m loan to support Kodak Pharmaceuticals pharmaceutical-technology
July 30, 2020
The US International Development Finance Corporation (DFC) has signed a letter of interest (LOI) to offer a $765m loan to support Eastman Kodak’s new arm, Kodak Pharmaceuticals.
Hetero launches Favivir to treat mild to moderate Covid-19 expresspharma
July 30, 2020
Favivir, priced at Rs 59 per tablet, will be available at all retail medical outlets and hospital pharmacies across the country but will be sold only on prescription.
Thermo Fisher Scientific Strengthens its Global Response to COVID-19 and continues to Support Development and Production of Therapeutics and Vaccines expresspharma
July 30, 2020
Thermo Fisher Scientific, the world leader in serving science, continues to expand global capacity and capabilities across its leading pharma services network to support customers in government, industry and academia as they accelerate development and ...
Actemra/RoActemra, arthritis drug from Roche fails to meet primary endpoint of COVID-19 trial expresspharma
July 30, 2020
The COVACTA study did not meet its primary endpoint of improved clinical status in hospitalised adult patients with severe COVID-19 associated pneumonia or identify any new safety signals for Actemra/RoActemra.
Inotrem gets clearance to launch phase 2 trial of Nangibotide in Covid-19 patients pharmaceutical-business-review
July 29, 2020
Inotrem S.A., a biotechnology company specialized in the development of immunotherapies targeting the TREM-1 pathway, announced that it has obtained authorization to launch its phase IIa clinical trial in COVID-19 patients in France, Belgium and the USA.
Avacta Provides Update on Clinical Validation of Adeptrix COVID-19 Diagnostic Test americanpharmaceuticalreview
July 29, 2020
Avacta, the developer of Affimer? biotherapeutics and reagents, has begun work with the UK government’s CONDOR program to evaluate and clinically validate the high throughput COVID-19 bead-assisted mass spectrometry (BAMS?) laboratory assay developed ...
EMA initiates review of dexamethasone for treating COVID-19 europeanpharmaceuticalreview
July 29, 2020
The EMA has begun to review dexamethasone to provide an opinion on the results of the RECOVERY study for the treatment of adults admitted to hospital with COVID-19.
Potential COVID-19 treatment LAM-002A to enter Phase II clinical trial europeanpharmaceuticalreview
July 29, 2020
Yale University and AI Therapeutics will collaborate on a Phase II trial to study LAM-002A as a COVID-19 treatment for newly diagnosed patients.
Haryana FDA files FIR against foreign nationals for illegal export of COVID-19 drugs expresspharma
July 29, 2020
Haryana Food and Drugs Administration (FDA) has filed an FIR against five foreign nationals for illegal export of COVID-19 drugs mainly; Covifor (remdesivir), FabiFlu and Lopikast.